435 Results (Page 3 of 37)
Clinical Trials Markets Research Reports
Nigeria Neurology Clinical Trials Market Analysis
The Nigeria Neurology Clinical Trials market is projected to grow from $4.71 Mn in 2022 to $7.79 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. The market will be driven by the high prevalence of neurological disorders and the development of a framework for aiding more clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Merck & Co.
Netherlands Neurology Clinical Trials Market Analysis
The Netherlands Neurology Clinical Trials market is projected to grow from $13.6 Mn in 2022 to $21.7 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The market will be driven by the modern healthcare infrastructure and an innovative & collaborative research environment. The market is segmented by phase, by study design & by indication. Some of the major players include Biogen Netherlands BV, Roche Holding AG & Johnson & Johnson.
Kenya Neurology Clinical Trials Market Analysis
The Kenya Neurology Clinical Trials market is projected to grow from $3.66 Mn in 2022 to $6.1 Mn by 2030, registering a CAGR of 6.6% during the forecast period of 2022 - 2030. The market will be driven by investments in healthcare infrastructure by the Kenyan government and a favourable regulatory environment. The market is segmented by phase, by study design & by indication. Some of the major players include Merck & Co., Inc., Novartis International AG, and Roche Holding AG.
Belgium Neurology Clinical Trials Market Analysis
The Belgium Neurology Clinical Trials market is projected to grow from $11.5 Mn in 2022 to $17.7 Mn by 2030, registering a CAGR of 5.5% during the forecast period of 2022 - 2030. The market will be driven by the rising prevalence of neurological disorders and a favourable regulatory environment. The market is segmented by phase, by study design & by indication. Some of the major players include UCB, Biogen Inc & Icometrix.
Vietnam Neurology Clinical Trials Market Analysis
The Vietnam Neurology Clinical Trials market is projected to grow from $26.2 Mn in 2022 to $40.8 Mn by 2030, registering a CAGR of 5.73% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses such as Alzheimer's, Parkinson's, and stroke along with improving healthcare infrastructure in Vietnam. The market is segmented by phase, by study design & by indication. Some of the major players include Biogen, Pfizer Inc. & Vietnam Pharmaceutical Corporation.
UK Neurology Clinical Trials Market Analysis
The UK Neurology Clinical Trials market is projected to grow from $342.2 Mn in 2022 to $451.4 Mn by 2030, registering a CAGR of 3.52% during the forecast period of 2022 - 2030. The market will be driven by increasing funding and assistance from institutions such as the NIHR as well as greater awareness and understanding of neurological disorders. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Biogen Inc & Cambridge Cognition Holdings PLC.
UAE Neurology Clinical Trials Market Analysis
The UAE Neurology Clinical Trials market is projected to grow from $26.2 Mn in 2022 to $43.3 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. The market will be driven by the modern healthcare infrastructure and a favourable regulatory environment that encourages investment in clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer, and Biogen.
Turkey Neurology Clinical Trials Market Analysis
The Turkey Neurology Clinical Trials market is projected to grow from $41.8 Mn in 2022 to $66.7 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses such as Alzheimer's, Parkinson's, and stroke and rising investment in research facilities. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Abdi İbrahim.
Thailand Neurology Clinical Trials Market Analysis
The Thailand Neurology Clinical Trials market is projected to grow from $6.28 Mn in 2022 to $9.88 Mn by 2030, registering a CAGR of 5.84% during the forecast period of 2022 - 2030. The market will be driven by the country's favourable regulatory environment, big patient pool, and highly qualified medical professionals. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Pfizer Inc. & Siam Bioscience Co., Ltd.
Spain Neurology Clinical Trials Market Analysis
The Spain Neurology Clinical Trials market is projected to grow from $100.9 Mn in 2022 to $143.5 Mn by 2030, registering a CAGR of 4.5% during the forecast period of 2022 - 2030. The market will be driven by well-established infrastructure, skilled researchers, and access to a big patient population. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc, Grifols, S.A. & Almirall, S.A.
South Korea Neurology Clinical Trials Market Analysis
The South Korea Neurology Clinical Trials market is projected to grow from $76.4 Mn in 2022 to $126.5 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. The market will be driven by the supportive regulatory environment and increasing interest from pharmaceutical companies investing in neurology clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Hoffmann-La Roche, Biogen & Chong Kun Dang Pharmaceutical.
Singapore Neurology Clinical Trials Market Analysis
The Singapore Neurology Clinical Trials market is projected to grow from $6.28 Mn in 2022 to $10.08 Mn by 2030, registering a CAGR of 6.1% during the forecast period of 2022 - 2030. The market will be driven by investments in clinical research and fostering collaborations between researchers, healthcare professionals, and industry partners. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Biogen & Invitrocue Pte Ltd.
Saudi Arabia Neurology Clinical Trials Market Analysis
The Saudi Arabia Neurology Clinical Trials market is projected to grow from $88.9 Mn in 2022 to $152.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the high prevalence of neurological disorders, and increasing investment in healthcare infrastructure. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Tabuk Pharmaceuticals.
Philippines Neurology Clinical Trials Market Analysis
The Philippines Neurology Clinical Trials market is projected to grow from $11.5 Mn in 2022 to $18.3 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The market will be driven by the country's growing clinical trial industry and a large pool of potential study participants. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Pfizer & Philippine Pharma Solutions, Inc.
Mexico Neurology Clinical Trials Market Analysis
The Mexico Neurology Clinical Trials market is projected to grow from $78.5 Mn in 2022 to $122.7 Mn by 2030, registering a CAGR of 5.75% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses and increased investments in R&D by pharmaceutical companies. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Laboratorios Silanes.
Global Clinical Trial Patient Recruitment Services Market Analysis
The Global clinical trial patient recruitment services market is projected to grow from $ 0.84 Mn in 2022 to $1.56 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-30. The Global clinical trial patient recruitment services market is a rapidly growing market that provides services to support the recruitment of patients for clinical trials. Some key players in the global clinical trial patient recruitment services market include IQVIA, Parexel International, PRA Health Sciences, Syneos Health, and WCG Clinical. Other important players include ICON plc, Medpace, Charles River Laboratories, and Premier Research.
Malaysia Neurology Clinical Trials Market Analysis
The Malaysia Neurology Clinical Trials market is projected to grow from $8.41 Mn in 2022 to $13.1 Mn by 2030, registering a CAGR of 5.7% during the forecast period of 2022 - 2030. The market will be driven by a well-developed healthcare infrastructure and a large pool of potential study participants. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Merck Sharp & Dohme Malaysia.
Japan Neurology Clinical Trials Market Analysis
The Japan Neurology Clinical Trials market is projected to grow from $325.1 Mn in 2022 to $518.1 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The market will be driven by the high prevalence of neurological diseases and a robust healthcare system. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer, Eisai Co., Ltd & Daiichi Sankyo.
Italy Neurology Clinical Trials Market Analysis
The Italy Neurology Clinical Trials market is projected to grow from $125.5 Mn in 2022 to $185.5 Mn by 2030, registering a CAGR of 5% during the forecast period of 2022 - 2030. The market will be driven by the rising demand for novel therapies for neurological disorders and the supportive regulatory climate in Italy. The market is segmented by phase, by study design & by indication. Some of the major players include AstraZeneca, Chiesi Farmaceutici & Menarini.
Indonesia Neurology Clinical Trials Market Analysis
The Indonesia Neurology Clinical Trials market is projected to grow from $31.4 Mn in 2022 to $48.2 Mn by 2030, registering a CAGR of 5.5% during the forecast period of 2022 - 2030. The market will be driven by the rising investments by global pharmaceutical companies in Indonesia due to reduced operating costs and improved healthcare infrastructure. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Roche & PT Dexa Medica.
India Neurology Clinical Trials Market Analysis
The India Neurology Clinical Trials market is projected to grow from $95.1 Mn in 2022 to $182.7 Mn by 2030, registering a CAGR of 8.5% during the forecast period of 2022 - 2030. The market will be driven by the high prevalence of neurological disorders and the low cost of conducting clinical trials in India. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Sun Pharmaceutical Industries & Cadila Healthcare.
Germany Neurology Clinical Trials Market Analysis
The Germany Neurology Clinical Trials market is projected to grow from $191.4 Mn in 2022 to $256 Mn by 2030, registering a CAGR of 3.7% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses such as Alzheimer's, Parkinson's, multiple sclerosis, and epilepsy and regulatory frameworks that encourage clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer & Bayer.
France Neurology Clinical Trials Market Analysis
The France Neurology Clinical Trials market is projected to grow from $279.3 Mn in 2022 to $371.1 Mn by 2030, registering a CAGR of 3.62% during the forecast period of 2022 - 2030. The market will be driven by the growing frequency of neurological diseases and the robust research infrastructure of France. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Sanofi SA & Neuraxpharm France SAS.
Egypt Neurology Clinical Trials Market Analysis
The Egypt Neurology Clinical Trials market is projected to grow from $14.6 Mn in 2022 to $25.2 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the increasing involvement from both global and local companies, a supportive regulatory environment and a growing pool of qualified professionals. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer, Novartis, Minapharm Pharmaceuticals & EIPICO.
China Neurology Clinical Trials Market Analysis
The China Neurology Clinical Trials market is projected to grow from $420.4 Mn in 2022 to $722.4 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the country's increasing incidence of neurological disorders and pharmaceutical firms boosting their investments in R&D. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer, Novartis, Shanghai Green Valley Pharmaceuticals & Jiangsu Hengrui Medicine.